Dave Richard

Prof. Dr. Dave Richard

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2018 in Cellular Microbiology
Verified
Journal Article
Closed access
PDF file
SHStéphanie Hallée
Stéphanie Hallée
NCNatalie A. Counihan
Natalie A. Counihan
KMKathryn Matthews
Kathryn Matthews
TKTania F. Koning‐Ward
Tania F. Koning‐Ward
DRDave Richard
Dave Richard

22 February 2022 in mBio
Verified
Journal Article
Open access
AMAngana Mukherjee
Angana Mukherjee
MCMarie-Ève Crochetière
Marie-Ève Crochetière
ASAudrey Sergerie
Audrey Sergerie
SASouad Amiar
Souad Amiar
LTL. Alexa Thompson
L. Alexa Thompson
DRDave Richard
Dave Richard
Malaria represents an enormous burden for a significant proportion of humanity and the lack of vaccines and problems with drug resistance to all antimalarials demonstrate the need to develop new therapeutics. Inhibitors of phosphoinositide metabolism are currently being developed as antimalarials but our understanding of this biological pathway is incomplete.

1 April 2018 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
AMAngana Mukherjee
Angana Mukherjee
DGDominic Gagnon
Dominic Gagnon
DWDyann F. Wirth
Dyann F. Wirth
DRDave Richard
Dave Richard
Dihydroartemisinin-piperaquine (DHA-PPQ), the current frontline artemisinin combination therapy used to treat Plasmodium falciparum malaria in multiple Southeast Asian countries, is now increasingly failing in Cambodia, where artemisinin resistance is nearly fixed, which suggests that PPQ resistance has emerged and is spreading rapidly in the Greater Mekong Subregion. Recent reports have shown that amplification of the genes encoding plasmepsins 2 and 3 is a molecular marker of PPQ resistance; however, whether these enzymes play a role in the mechanism of resistance is currently unknown. We show here that inactivating the genes encoding plasmepsin 2 or 3 individually in P. falciparum reference strain 3D7 results in hypersusceptibility to PPQ. Interestingly, no significant differences in the susceptibility to other antimalarials were observed, which suggests specific roles of plasmepsins 2 and 3 in PPQ susceptibility. The piperaquine hyper-sensitivity of the plasmepsin-2-and-3-inactivated lines provides direct evidence that these enzymes modulate parasite susceptibility to PPQ in the context of a single copy of PfMDR1 and independent of Kelch13 mutations conferring artemisinin resistance.

16 May 2019 in EMBO Reports
Verified
Journal Article
Open access
PDF file
ZEZeinab Ebrahimzadeh
Zeinab Ebrahimzadeh
AMAngana Mukherjee
Angana Mukherjee
MCMarie‐Ève Crochetière
Marie‐Ève Crochetière
ASAudrey Sergerie
Audrey Sergerie
SASouad Amiar
Souad Amiar
DRDave Richard
Dave Richard
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

28 February 2018 in mSphere
Verified
Journal Article
Open access
PDF file
SHStéphanie Hallée
Stéphanie Hallée
JBJustin A. Boddey
Justin A. Boddey
ACAlan F. Cowman
Alan F. Cowman
DRDave Richard
Dave Richard
The malaria parasite is a massive burden in several parts of the world. Worryingly, the parasite has become resistant to several of the drugs commonly used to treat the disease, and at this time, there is no commercial vaccine. It is therefore critical to identify new targets for the development of antimalarials. To survive in the human body, the malaria parasite needs to invade red blood cells. For this, it uses a variety of effectors stored in organelles forming a structure called the apical complex. The mechanisms behind how the parasite generates the apical complex are poorly understood. In this study, we present evidence that a transmembrane protein called sortilin potentially acts as an escorter to transport proteins from the Golgi apparatus to the rhoptries, a component of the apical complex. Our study provides new insight into the biogenesis of a critical structure of the malaria parasite.

1 January 2018 in International Journal for Parasitology
Verified
Journal Article
Closed access
ZEZeinab Ebrahimzadeh
Zeinab Ebrahimzadeh
AMAngana Mukherjee
Angana Mukherjee
DRDave Richard
Dave Richard